CDK46 Inhibitor to Treat Breast Cancer
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Individualizing Therapy for HR-Positive/HER2-Negative MBC

Released: October 09, 2024

Expiration: October 08, 2025

Julia A LaBarbera
Julia A LaBarbera, MSN, RN, AGACNP-BC

Activity

Progress
1
Course Completed